BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7045225)

  • 1. Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
    Ralph P; Williams N; Nakoinz I; Jackson H; Watson JD
    J Immunol; 1982 Jul; 129(1):427-32. PubMed ID: 7045225
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on mouse macrophage activation. II. Dissociation of the suppressive effects of macrophages on lymphocytes vs tumor cells].
    Sun DM; Shi W; Hu XZ; Lu S; Zhang YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):176-80. PubMed ID: 2939970
    [No Abstract]   [Full Text] [Related]  

  • 4. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
    Ralph P
    Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of natural tumor resistance by tumor promoters.
    Keller R; Keist R; Köppel P; Hecker E
    Carcinog Compr Surv; 1982; 7():643-5. PubMed ID: 7039836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
    Ralph P; Nakoinz I
    J Immunol; 1977 Sep; 119(3):950-54. PubMed ID: 894031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.
    Lee KC; Wong M; McIntyre D
    J Immunol; 1981 Jun; 126(6):2474-9. PubMed ID: 6971902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
    Drysdale BE; Shin HS
    J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytokines and receptors--their functions, structures and cloning of code genes. Macrophage activating factor].
    Taniyama T
    Nihon Rinsho; 1988 May; 46(5):1056-61. PubMed ID: 3137378
    [No Abstract]   [Full Text] [Related]  

  • 14. [The in vitro effect of silica fibers on macrophage-mediated cytotoxic activities in mice].
    Yin L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):287-92. PubMed ID: 2558812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the effects of endotoxin on macrophage tumor cell killing.
    Weinberg JB; Chapman HA; Hibbs JB
    J Immunol; 1978 Jul; 121(1):72-80. PubMed ID: 27559
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of macrophage cytotoxicity to tumors and production of megakaryocyte-stimulating factors by microbial agents.
    Ralph P; Williams N; Nakoinz I; Jackson H; Ito M; Azuma I; Yamamura Y
    Kekkaku; 1980 Nov; 55(11):499-503. PubMed ID: 6970296
    [No Abstract]   [Full Text] [Related]  

  • 19. Function and role of peritoneal macrophages in experimental leukaemia.
    Thi Phi Phi P; Nedelkova M; Serafimov-Dimitrov V
    Haematologia (Budap); 1981; 14(1):29-38. PubMed ID: 7250816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity.
    Baxter CS; Fish LA; Ferguson TA; Michael JG; Bash JA
    Carcinog Compr Surv; 1982; 7():637-42. PubMed ID: 6978182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.